RGS9

RGS9

Target · GTPase-activating protein

RGS9 Regulator of G protein signalling 9 · RGS9L

RGS9 (regulator of G protein signalling 9, also known as PERRS or RGS9L) is a GTPase-activating protein that switches off G protein signalling. It is anchored to photoreceptor membranes and is a key element in the recovery phase of visual transduction. Browse Assay Genie's current range of RGS9 research reagents below, or read on for the biology behind the target.

Membrane-anchoredG protein GAPLinked to bradyopsia
674 aa
Protein length
~77 kDa
Molecular weight
17q24.1
Gene locus
RGS family
Protein family
Target information

What is RGS9 (regulator of G protein signalling 9)?

RGS9 inhibits signal transduction by increasing the GTPase activity of G protein alpha subunits, driving them into their inactive GDP-bound form. In this way it accelerates the deactivation of G proteins, a general mechanism shared by members of the RGS family of GTPase-activating proteins. RGS9 binds to GNAT1, the rod transducin alpha subunit, and is involved in phototransduction, where it is a key element in the recovery phase of visual transduction.

The RGS9 protein is anchored to photoreceptor membranes in retinal cells, where it deactivates G proteins in both the rod and cone phototransduction cascades. The RGS9 gene is classed by HGNC within the regulators of G-protein signalling and the DEP domain containing gene groups. Multiple transcript variants encoding different isoforms have been found for this gene, and the long form is referred to by the alias RGS9L. Mouse and rat both have an Rgs9 ortholog.

Mutations in the RGS9 gene result in bradyopsia, which makes the protein relevant to studies of visual recovery and retinal disease. Earlier names include regulator of G-protein signalling 9, and further aliases include PERRS, MGC26458 and MGC111763. Researchers studying RGS9 often examine it alongside other RGS proteins to compare how each family member regulates G protein deactivation.

Phototransduction research

RGS9 is a key element in the recovery phase of visual transduction, acting in both rod and cone cascades.

G protein signalling

RGS9 increases the GTPase activity of G protein alpha subunits, making it a model for studying G protein deactivation.

Retinal disease studies

Mutations in the RGS9 gene result in bradyopsia, linking the protein to inherited disorders of visual function.

Photoreceptor membrane biology

RGS9 is anchored to photoreceptor membranes in retinal cells, supporting work on how signalling proteins are organised there.

Background

RGS9 frequently asked questions

What does RGS9 do?

RGS9 increases the GTPase activity of G protein alpha subunits, driving them into their inactive GDP-bound form and so inhibiting signal transduction. It binds GNAT1 and is a key element in the recovery phase of visual transduction in rod and cone photoreceptors.

What other names and isoforms does RGS9 have?

RGS9 is also known as PERRS, RGS9L, MGC26458 and MGC111763, and was previously named regulator of G-protein signalling 9. Multiple transcript variants encoding different isoforms have been reported for the gene, according to the NCBI Gene summary.

Is RGS9 linked to disease and conserved in other species?

Mutations in the RGS9 gene result in bradyopsia, a disorder of visual function. Mouse and rat each have an Rgs9 ortholog. Check the datasheet of any product for its validated reactivity.

Explore

Related targets

Other members of the RGS family of GTPase-activating proteins that regulate G protein signalling.

Gene and protein annotations from HGNC, NCBI Gene and UniProt O75916; product specifications from Assay Genie datasheets.

RGS9 Product listing